XClose

UCL Cancer Institute

Home
Menu

Cancer Research UK Brain Tumour Centre of Excellence

The CRUK Brain Tumour Centre of Excellence at Edinburgh University and UCL is dedicated to the discovery and clinical evaluation of new brain cancer therapeutics.

There are over 150 brain tumour types. They can be classified based on the type of cell they grow from, their location in the brain and how likely they are to spread. Tumours are graded by the cell activity and aggressiveness on a scale of I to IV. Treatment options vary depending on the cell type, grade, size, and location of the tumour. The most common type of primary brain cancer in adults is glioblastoma originating from glial cells. Glioblastoma spreads quickly and invades other parts of the brain - it is challenging to treat.  

Brain cancer survival remains low, and has changed little in over a generation. With more than 11,000 new cases of brain tumours in the UK each year and 10-year survival rate of less than 15% there is a pressing need for development of better treatments. 

The CRUK Centre Brain Tumourr Centre of Excellence aims to help deliver a step change in glioma research in the UK by bringing together world-leading experts to advance understanding of the biology underpinning the disease and explore new avenues for diagnosis and personalised treatment.  


Research focus and strategic partnerships

Brain scans

About the Centre

Transforming the UK landscape for discovery and clinical evaluation of new brain cancer therapeutics for glioblastoma.

Glioma Club Brain Cancer Centre of Excellence Annual Conference

Glioma Cellular Genetics Resource

A collection of cellular models and associated data to underpin the next era of studies into the biology and treatment of glioma.

Glioma Cellular Genetics Resource

Annual conference

The first annual conference (Glioma Club) of the Brain Tumour Centre will take place Wednesday 3 July 2019 and will open this year's annual BNOS meeting.

Patient engagement

Patient engagement

Connecting researchers to patients, local communities and wider society.